Key result
Tumor resection, chest wall reconstruction, and postoperative adjuvant radiotherapy resulted in no evidence of tumor recurrence during a one-year follow-up in a patient with sternal EHE.
Case Report (n=1)
Tumor resection, chest wall reconstruction, and adjuvant radiotherapy successfully treated a rare case of sternal epithelioid hemangioendothelioma with no recurrence at one year.
Supports feasibility of multimodality therapy for sternal EHE; hypothesis-generating and requires validation in larger cohorts.
Epithelioid hemangioendothelioma (EHE) is a rare vascular tumor composed of dendritic and endothelial cells, and accounts for less than 1% of all vascular tumors. The tumor may arise from any location in the body, but it has a predilection for veins of the extremities, the liver, bone, and skin. Herein, we report a case of a 43-year-old man who presented with a chest mass accompanied by chest pain. Computed tomography (CT) scan of the chest showed a 3 cm × 2 cm sternal mass in the chest wall. We performed tumor resection and reconstruction of the chest wall. EHE was confirmed via postoperative pathology. The patient underwent postoperative adjuvant radiotherapy, and no evidence of tumor recurrence was discovered during the one-year follow up.
No takes yet. Share an insight, caveat, or question.
Song et al. (2020) conducted a case report in Epithelioid hemangioendothelioma of the sternum (n=1). Tumor resection, chest wall reconstruction, and postoperative adjuvant radiotherapy was evaluated on Tumor recurrence. Tumor resection, chest wall reconstruction, and postoperative adjuvant radiotherapy resulted in no evidence of tumor recurrence during a one-year follow-up in a patient with sternal EHE.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: